vs
NEOGEN CORP（NEOG）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
NEOGEN CORP的季度营收约是ROGERS CORP的1.1倍（$224.7M vs $200.5M），ROGERS CORP净利率更高（2.2% vs -7.1%，领先9.3%），ROGERS CORP同比增速更快（5.2% vs -2.8%），NEOGEN CORP自由现金流更多（$7.8M vs $1.1M），过去两年NEOGEN CORP的营收复合增速更高（-0.9% vs -3.3%）
Neogen Corporation是一家1982年成立、总部位于美国密歇根州兰辛的跨国食品安全企业，专注提供各类检测试剂盒及相关产品，用于筛查食品中的有害成分。目前业务覆盖美国、加拿大、英国、欧洲部分地区、墨西哥、巴西、印度、中国等多个国家，旗下拥有超100款药物检测试剂盒产品，可检测约300种相关违禁物质。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
NEOG vs ROG — 直观对比
营收规模更大
NEOG
是对方的1.1倍
$200.5M
营收增速更快
ROG
高出8.1%
-2.8%
净利率更高
ROG
高出9.3%
-7.1%
自由现金流更多
NEOG
多$6.7M
$1.1M
两年增速更快
NEOG
近两年复合增速
-3.3%
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $224.7M | $200.5M |
| 净利润 | $-15.9M | $4.5M |
| 毛利率 | 47.5% | 32.2% |
| 营业利润率 | -2.4% | — |
| 净利率 | -7.1% | 2.2% |
| 营收同比 | -2.8% | 5.2% |
| 净利润同比 | 96.5% | 421.4% |
| 每股收益（稀释后） | $-0.07 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEOGROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $224.7M | $201.5M | ||
| Q3 25 | $209.2M | $216.0M | ||
| Q2 25 | $225.4M | $202.8M | ||
| Q1 25 | $221.0M | $190.5M | ||
| Q4 24 | $231.3M | $192.2M | ||
| Q3 24 | $217.0M | $210.3M | ||
| Q2 24 | $236.8M | $214.2M |
净利润NEOGROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-15.9M | $4.6M | ||
| Q3 25 | $36.3M | $8.6M | ||
| Q2 25 | $-612.3M | $-73.6M | ||
| Q1 25 | $-10.9M | $-1.4M | ||
| Q4 24 | $-456.3M | $-500.0K | ||
| Q3 24 | $-12.6M | $10.7M | ||
| Q2 24 | $-5.4M | $8.1M |
毛利率NEOGROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 47.5% | 31.5% | ||
| Q3 25 | 45.4% | 33.5% | ||
| Q2 25 | 41.2% | 31.6% | ||
| Q1 25 | 49.9% | 29.9% | ||
| Q4 24 | 49.0% | 32.1% | ||
| Q3 24 | 48.4% | 35.2% | ||
| Q2 24 | 47.9% | 34.1% |
营业利润率NEOGROG
| Q1 26 | — | — | ||
| Q4 25 | -2.4% | 3.5% | ||
| Q3 25 | -7.7% | 7.3% | ||
| Q2 25 | -271.1% | -33.3% | ||
| Q1 25 | 2.4% | -0.2% | ||
| Q4 24 | -197.8% | -6.6% | ||
| Q3 24 | 1.0% | 6.9% | ||
| Q2 24 | 5.5% | 5.3% |
净利率NEOGROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -7.1% | 2.3% | ||
| Q3 25 | 17.4% | 4.0% | ||
| Q2 25 | -271.6% | -36.3% | ||
| Q1 25 | -4.9% | -0.7% | ||
| Q4 24 | -197.3% | -0.3% | ||
| Q3 24 | -5.8% | 5.1% | ||
| Q2 24 | -2.3% | 3.8% |
每股收益（稀释后）NEOGROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.07 | $0.20 | ||
| Q3 25 | $0.17 | $0.48 | ||
| Q2 25 | $-2.82 | $-4.00 | ||
| Q1 25 | $-0.05 | $-0.08 | ||
| Q4 24 | $-2.10 | $-0.04 | ||
| Q3 24 | $-0.06 | $0.58 | ||
| Q2 24 | $-0.02 | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $145.3M | $195.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $1.2B |
| 总资产 | $3.4B | $1.4B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEOGROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $145.3M | $197.0M | ||
| Q3 25 | $138.9M | $167.8M | ||
| Q2 25 | $129.0M | $157.2M | ||
| Q1 25 | $127.7M | $175.6M | ||
| Q4 24 | $140.2M | $159.8M | ||
| Q3 24 | $120.5M | $146.4M | ||
| Q2 24 | $170.9M | $119.9M |
股东权益NEOGROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $2.1B | $1.2B | ||
| Q3 25 | $2.1B | $1.2B | ||
| Q2 25 | $2.1B | $1.2B | ||
| Q1 25 | $2.7B | $1.3B | ||
| Q4 24 | $2.7B | $1.3B | ||
| Q3 24 | $3.1B | $1.3B | ||
| Q2 24 | $3.1B | $1.3B |
总资产NEOGROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $3.4B | $1.4B | ||
| Q3 25 | $3.4B | $1.4B | ||
| Q2 25 | $3.4B | $1.5B | ||
| Q1 25 | $4.0B | $1.5B | ||
| Q4 24 | $4.1B | $1.5B | ||
| Q3 24 | $4.5B | $1.5B | ||
| Q2 24 | $4.5B | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $7.8M | $1.1M |
| 自由现金流率自由现金流/营收 | 3.5% | 0.5% |
| 资本支出强度资本支出/营收 | 5.2% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $-18.5M | $70.1M |
8季度趋势，按日历期对齐
经营现金流NEOGROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $19.4M | $46.9M | ||
| Q3 25 | $10.9M | $28.9M | ||
| Q2 25 | $16.4M | $13.7M | ||
| Q1 25 | $19.5M | $11.7M | ||
| Q4 24 | $40.3M | $33.7M | ||
| Q3 24 | $-17.9M | $42.4M | ||
| Q2 24 | $26.7M | $22.9M |
自由现金流NEOGROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $7.8M | $42.2M | ||
| Q3 25 | $-13.1M | $21.2M | ||
| Q2 25 | $349.0K | $5.6M | ||
| Q1 25 | $-13.4M | $2.1M | ||
| Q4 24 | $23.1M | $18.3M | ||
| Q3 24 | $-56.3M | $25.2M | ||
| Q2 24 | $2.5M | $8.8M |
自由现金流率NEOGROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 3.5% | 20.9% | ||
| Q3 25 | -6.3% | 9.8% | ||
| Q2 25 | 0.2% | 2.8% | ||
| Q1 25 | -6.1% | 1.1% | ||
| Q4 24 | 10.0% | 9.5% | ||
| Q3 24 | -26.0% | 12.0% | ||
| Q2 24 | 1.1% | 4.1% |
资本支出强度NEOGROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 5.2% | 2.3% | ||
| Q3 25 | 11.5% | 3.6% | ||
| Q2 25 | 7.1% | 4.0% | ||
| Q1 25 | 14.9% | 5.0% | ||
| Q4 24 | 7.4% | 8.0% | ||
| Q3 24 | 17.7% | 8.2% | ||
| Q2 24 | 10.2% | 6.6% |
现金转化率NEOGROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | 0.30× | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NEOG
| Other | $109.2M | 49% |
| Bacterial And General Sanitation | $44.9M | 20% |
| Services | $25.7M | 11% |
| Natural Toxins And Allergens | $20.4M | 9% |
| Animal Care | $8.9M | 4% |
| Genomics Services | $6.3M | 3% |
| Biosecurity Products | $4.6M | 2% |
| Life Sciences | $1.4M | 1% |
ROG
暂无分部数据
